Most Recent Articles by Stephen Cho
Ongoing use of androgen-deprivation therapy (ADT) for up to 36 months is not associated with cognitive decline among men with prostate cancer.
Men with low-risk prostate cancer who undergo open or robot-assisted radical prostatectomy may have favorable oncological outcomes.
Low serum testosterone levels within the first year of androgen-deprivation therapy (ADT) is associated with improved cause-specific survival.
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).
More Articles by Stephen Cho
Renal and Urology News Articles
- The Threat From Within: Most Breaches Due to Employee Errors
- Radical Prostatectomy Has Lasting Benefit for Localized Cancer
- Poor Vitamin K Status Linked to Low BMD, Increased Fracture Risk in ESRD
- Serum Phosphate at Dialysis Start Tied With Mortality
- Veterans Health Administration Hospitals Outperform Non-VHAs
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)